Tech Company Financing Transactions
Omthera Pharmaceuticals Funding Round
Omthera Pharmaceuticals, based in Princeton, secured $2.5 million from New Enterprise Associates.
Transaction Overview
Company Name
Announced On
6/30/2012
Transaction Type
Venture Equity
Amount
$2,500,000
Round
Undisclosed
Investors
New Enterprise Associates (David Mott)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
707 State Road
Princeton, NJ 08540
USA
Princeton, NJ 08540
USA
Phone
Website
Email Address
Overview
Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceuticals company with an experienced team of experts in drug development and the Pharmaceutical industry focusing its efforts on the clinical development of new therapies for dyslipidemia.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jerry Wisler
Chief Financial Officer
Christian Schade
Chief Medical Officer
Michael Davidson
Chief Operating Officer
Ben Machielse
Controller
Douglas Carr
Browse more venture capital transactions:
Prev: 6/30/2012: Innotas venture capital transaction
Next: 6/30/2012: Calient Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs